Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer.
about
Towards decision-making using individualized risk estimates for personalized medicine: A systematic review of genomic classifiers of solid tumors.Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer.Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung CancerThe Case for Adolescent HIV Vaccination in South Africa: A Cost-Effectiveness Analysis.
P2860
Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cost-effectiveness of a 14-gen ...... us non-small cell lung cancer.
@ast
Cost-effectiveness of a 14-gen ...... us non-small cell lung cancer.
@en
Cost-effectiveness of a 14-gen ...... us non-small cell lung cancer.
@nl
type
label
Cost-effectiveness of a 14-gen ...... us non-small cell lung cancer.
@ast
Cost-effectiveness of a 14-gen ...... us non-small cell lung cancer.
@en
Cost-effectiveness of a 14-gen ...... us non-small cell lung cancer.
@nl
prefLabel
Cost-effectiveness of a 14-gen ...... us non-small cell lung cancer.
@ast
Cost-effectiveness of a 14-gen ...... us non-small cell lung cancer.
@en
Cost-effectiveness of a 14-gen ...... us non-small cell lung cancer.
@nl
P2093
P2860
P1433
P1476
Cost-effectiveness of a 14-gen ...... us non-small cell lung cancer.
@en
P2093
Josh J Carlson
Joshua A Roth
Paul Billings
Robert Dumanois
Scott D Ramsey
P2860
P304
P356
10.1634/THEONCOLOGIST.2013-0357
P577
2014-04-07T00:00:00Z